Memphis Grizzlies forward Brandon Clarke eligible for injection in right knee

The Memphis Grizzlies announced today that forward Brandon Clarke has opted for injections rather than surgery to treat his right knee injury.

This decision was reached after the team had multiple medical consultations. Clark has now completed the injection treatment and will enter the rehabilitation stage. According to the current plan, Clark is expected to return to the court at the beginning of next season.

Clark, 28, was injured in a game in mid-March when the Memphis Grizzlies played against the Portland Trail Blazers. Clark fell after a confrontation in the first quarter of the game, causing his right knee to be injured.

A few days after the game, Clark was diagnosed with a serious injury to the posterior cruciate ligament of his right knee. On March 22, the Memphis Grizzlies officially announced that Clark would be out for the season and would focus on treatment.

During the recovery process, Clark had several consultations with the team's medical team and several experts, and finally decided to use non-surgical treatment, relying on injection therapy and rehabilitation training to repair Clark's right knee injury.

In fact, this decision not only helps Clark avoid a longer recovery period caused by surgery, but also reduces potential surgical risks. It can be said to be the best and most suitable decision.

In this season, Clark played in a total of 64 games, averaging 8.3 points and 5.1 rebounds per game, and averaged 18.9 minutes on the court. Although Clark's season ended early, the team and fans still expect him to return in a healthy state in the new season and make more contributions to the Memphis Grizzlies.